DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
ATEC logo

Alphatec Holdings, Inc. Stock Price

NasdaqGS:ATEC Community·US$1.6b Market Cap
  • 3 Narratives written by author
  • 1 Comments on narratives written by author
  • 16 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

ATEC Share Price Performance

US$10.58
-4.47 (-29.70%)
​
US$16.00
Fair Value
US$10.58
-4.47 (-29.70%)
33.9% undervalued intrinsic discount
US$16.00
Fair Value
Price US$10.58
AnalystConsensusTarget US$16.00
AnalystHighTarget US$22.41
AnalystLowTarget US$12.00
Mon, 20 Jul 26
Fair ValueUS$16.00
Share Pricen/a

ATEC Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$16 33.9% undervalued intrinsic discount

ATEC: Improved Margins And Revenue Projections Will Shape Future Performance

0users have liked this narrative
1users have commented on this narrative
11users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$22.41 52.8% undervalued intrinsic discount

Aging Population And Minimally Invasive Care Will Drive Expansion

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$12 11.8% undervalued intrinsic discount

Rising Cost Containment And Stricter Regulation Will Limit Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
ATEC logo
Alphatec Holdings
11.8% undervalued intrinsic discount

Rising Cost Containment And Stricter Regulation Will Limit Margins

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 19 Aug
Read Narrative
ATEC logo
Alphatec Holdings
52.8% undervalued intrinsic discount

Aging Population And Minimally Invasive Care Will Drive Expansion

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 5 Aug
Read Narrative
ATEC logo
Alphatec Holdings
33.9% undervalued intrinsic discount

ATEC: Improved Margins And Revenue Projections Will Shape Future Performance

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 20 Jul
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
ATEC logo

ATEC: Margin Progress And 2026 Outlook Will Support Future Upside

Fair Value: US$12 11.8% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
ATEC logo

ATEC: 2026 Revenue Mix Will Support Constructive Upside Case

Fair Value: US$22.41 52.8% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
ATEC logo

ATEC: 2026 Surgical Revenue Outlook Will Drive Future Upside Potential

Fair Value: US$16 33.9% undervalued intrinsic discount
11 fair values setusers have set this as their fair value
1 commentusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Undervalued with reasonable growth potential.

0 Risks
3 Rewards
View Full Analysis

Alphatec Holdings, Inc. Key Details

US$815.1m

Revenue

US$237.7m

Cost of Revenue

US$577.4m

Gross Profit

US$687.4m

Other Expenses

-US$110.0m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-0.71
70.84%
-13.50%
4,991.8%
View Full Analysis

About ATEC

Founded
1990
Employees
913
CEO
Patrick Miles
WebsiteView website
www.atecspine.com

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.

Recent ATEC News & Updates

User avatar
Narrative Update • Aug 19

ATEC: Margin Progress And 2026 Outlook Will Support Future Upside

Analysts have increased their price target for Alphatec Holdings from $11.00 to $12.00, citing updated assumptions on fair value, discount rate, revenue growth, profit margins, and a very large forward P/E estimate. What's in the News for Alphatec Holdings Alphatec Holdings reported Q2 revenue growth of about 15% with adjusted EBITDA up approximately 53%, highlighting progress on margins and continued double digit top line expansion.

Recent updates

No updates

Alphatec Holdings, Inc. Competitors

PODD logo

Insulet

Symbol: NasdaqGS:PODD
Market cap: US$9.2b
HQY logo

HealthEquity

Symbol: NasdaqGS:HQY
Market cap: US$8.0b
HNGE logo

Hinge Health

Symbol: NYSE:HNGE
Market cap: US$7.1b
PACS logo

PACS Group

Symbol: NYSE:PACS
Market cap: US$7.1b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide